Open AccessAdvantages and disadvantages of combined mucolytic therapy in children
Author(s) -
Ю. Л. Мизерницкий,
M.D. Shakhnazarova
Publication year - 2020
Publication title -
rossijskij vestnik perinatologii i pediatrii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.139
H-Index - 4
eISSN - 2500-2228
pISSN - 1027-4065
DOI - 10.21508/1027-4065-2019-64-6-114-118
Subject(s) - expectorant , intensive care medicine , medicine , bronchitis , drug , clinical practice , chronic bronchitis , bronchial obstruction , pharmacotherapy , pharmacology , asthma , physical therapy
The article discusses in detail advantages and disadvantages of combined mucolytic therapy in children, the requirements for the composition and purpose of such drugs. Such drug as Ascoril expectorant is considered to be a successful combination, pathogenetic mechanisms of the synergistic action of its components. The clinical experience of Ascoril expectorant application demonstrated its high clinical efficacy and safety, which makes it the first choice for bronchitis, mild bronchial obstruction in outpatient pediatric practice